购物车
全部删除
您的购物车当前为空
Sunagrel是一种phenylethanolamine的衍生物,由Maggioni Farmaceutici S.p.A.申请专利,主要用于抑制血小板聚集并作为降低血脂的药剂。

Sunagrel是一种phenylethanolamine的衍生物,由Maggioni Farmaceutici S.p.A.申请专利,主要用于抑制血小板聚集并作为降低血脂的药剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
Sunagrel 相关产品
| 产品描述 | Sunagrel, a derivative of phenylethanolamine, was patented by Maggioni Farmaceutici S.p.A., primarily serving as an inhibitor of platelet aggregation and an antilipidaemic agent. |
| 分子量 | 424.6 |
| 分子式 | C25H32N2O2S |
| CAS No. | 85418-85-5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容